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Objective: Necrotizing enterocolitis (NEC) is associated with high
morbidity and mortality among infants admitted for intensive care.
The factors associated with mortality and catastrophic presentation remain
poorly understood. Our objective was to describe the factors associated with
mortality in infants with NEC and to quantify the degree to which
catastrophic presentation contributes to mortality in infants with NEC.
Catastrophic NEC was deﬁned before data analysis as NEC that led to death
within 7 days of diagnosis.
Study Design: We performed a retrospective review of the Pediatrix’s
Clinical Data Warehouse (1997 to 2009, n¼560,227) to compare the
demographic, therapeutic and outcome characteristics of infants who
survived NEC vs those who died. Associations were tested by bivariate and
multivariate analysis.
Result: We compared the 5594 infants diagnosed with NEC and who
were discharged home with 1505 infants diagnosed with NEC who died.
In multivariate analysis, the factors associated with death (P<0.01
in analysis) were lower estimated gestational age, lower birth weight,
treatment with assisted ventilation on the day of diagnosis of NEC,
treatment with vasopressors at the time of diagnosis, and Black race.
Patients who received only ampicillin and gentamicin on the day of
diagnosis were less likely to die. Two-thirds of NEC deaths occurred
quickly (<7 days from diagnosis), with a median time of death of one
day from time of diagnosis. Infants who died within 7 days of diagnosis
had a higher birth weight, more often were on vasopressors and high
frequency ventilation at the time of diagnosis compared with patients who
died at 7 or more days. Although mortality decreased with increasing
gestational age, the proportion of deaths that occurred within 7 days
was relatively consistent (65 to 75% of the patients who died) across all
gestational ages.
Conclusion: Mortality among infants who have NEC remains high and
infants who die of NEC commonly (66%) die quickly. Most of the factors
associated with mortality are related to immaturity, low birth weight and
severity of illness.
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Introduction
Necrotizing enterocolitis (NEC) is a common cause of morbidity
in infants born prematurely.
1 Our understanding of predictors of
NEC outcomes has been limited to date and we do not have a full
understanding of why some patients die and others do not. Rapidly
progressive NEC that results in complete bowel necrosis in an
otherwise well infant is also poorly understood and not well
described in the literature.
2 Some cases progress so quickly that they
may never make it to surgery, making the distinctions of medical
and surgical NEC inadequate surrogates for severity of illness. The
purpose of this study was to investigate the factors associated with
NEC mortality and speciﬁcally to delineate the difference between
infants who die within 7 days of diagnosis from those that die later.
Methods
Research design
We performed a retrospective review of the Pediatrix Medical Group
de-identiﬁed database to compare the demographic, therapeutic
and outcome characteristics of infants who developed NEC and
survived to those who developed NEC and died.
De-identiﬁed data set
Pediatrix Medical Group provides intensive care services in 275
hospitals in 33 states and Puerto Rico. Pediatrix Medical Group
health care professionals providing care to infants admitted for
intensive care use a proprietary software system to generate clinical
admission, discharge and daily progress notes. Each day’s notes
are stored with diagnoses. The local data are consolidated within
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and made compliant with Health Insurance Portability and
Accountability Act of 1996 regulations.
Cases of patients with NEC were identiﬁed by searching the
diagnosis table in our database for the term ‘Necrotizing
Enterocolitis.’ Patients with this diagnosis were included in our
study cohort that evaluated the risk factors associated with death.
Infants who died in the delivery room or those who were not
admitted to the neonatal intensive care unit were not included in
the data set. Data on estimated gestational age (EGA) represented
the best estimates from both obstetrical data and neonatal
examination ﬁndings. The Western Institutional Review Board has
approved our research with the de-identiﬁed data set annually.
Our analytical approach to these data was descriptive in nature.
Deﬁnition of NEC
We deﬁned NEC to be present if, in our database, a diagnosis
of NEC was recorded. Infants with this diagnosis had one or more
of the following clinical signs: bilious gastric aspirate or emesis,
abdominal distention, blood in stool without evidence of a rectal
ﬁssure; and had one or more of the following radiographic
ﬁndings: pneumatosis intestinalis, hepatobiliary gas or
pneumoperitoneum. Either NEC-medical or NEC-surgical may be
chosen at the time of data entry. Patients who had a diagnosis
of NEC-medical who subsequently were treated with surgery
(had both diagnoses) were assigned to the NEC-surgical group.
All patients having a diagnosis of NEC-medical or NEC-surgical
were included in our analysis of NEC. We also reviewed the surgical
procedure to identify infants who had abdominal surgery for NEC
or bowel perforation, and included them in the NEC-surgical
if they were initially coded as NEC-medical. Infants with a
diagnosis of isolated intestinal perforation and no evidence of NEC
were excluded. Infants with a diagnosis of suspected NEC were also
excluded. Catastrophic NEC was deﬁned before data analysis as
NEC that led to death within 7 days of diagnosis.
Mortality
Mortality was examined for all infants from the time of diagnosis
during the initial hospitalization; we did not follow infants who
were initially discharged or transferred and subsequently died. We
also examined infants who were diagnosed with NEC and died
within 7 days after diagnosis and compared these infants with
patients who died more than 7 days following a diagnosis of NEC.
Statistical analysis
Before beginning our analysis, the available literature was reviewed
to identify factors previously associated with the death related to
NEC. Each of these prospectively identiﬁed factors was evaluated by
bivariate and multivariate analysis. During the bivariate analysis,
all of the numeric data (birth weight, EGA, APGAR score and
length of hospital stay) were evaluated using both parametric
(analysis of variance or two-sample t-test) and non-parametric test
(Kruskal–Wallis non-parametric test and Mann–Whitney test).
When the data were non-parametric, we used the Kruskal–Wallis
non-parametric test when making more than two comparisons
and the Mann–Whitney test for two-sample comparisons.
After bivariate analysis, multivariate logistic regression was used to
identify factors independently associated with death. We developed
our model by incorporating the variables that were found to have
signiﬁcant interactions (P<0.1) with the rate of NEC. Variables
were entered into the model using a stepwise selection (P-value for
entry and retention P<0.1). Cases with missing values for any of
the independent variables were excluded from the analysis. Only
variables with adjusted odds ratio (AOR) 95% CI that did not cross
1 were considered to have an independent and signiﬁcant
association with mortality.
Results
Study population
Between 1 January 1997 and 1 March 2009, there were 560227
infants that were entered into the Pediatrix Clinical Data
Warehouse. There were 6460 (1.2%) with a diagnosis of medically
treated NEC and 2661 (0.5%) with a report of surgically treated
NEC. There were 4346 (0.8%) with a diagnosis of suspected NEC
and 1929 (0.3%) with spontaneous intestinal perforation; both of
these groups of infants were excluded. NEC occurred at all EGA and
the occurrence decreased with increasing EGA (Figure 1).
Of the 9121 infants with medically or surgically treated NEC,
5594 (61.3%) were discharged home, 1574 (17.3%) were
transferred to another hospital before discharge, 1505 (16.5%) died,
403 (4.4%) were transferred to another service within the hospital
of birth, and data were missing on discharge status in 38 (0.4%)
infants. In this study, we compared the 5594 infants known to have
lived and been discharged home with the 1505 infants known
to have died. In addition, to better understand the factors associated
with rapidly progressive NEC, we compared the 993 infants
who died within 7 days of diagnosis to the 512 infants who
died 7 or more days after diagnosis.
Differences between infants who survived and those that died
In bivariate analysis, infants who died were smaller, more
immature, more often male, more often Black and less often White
than infants who had NEC and lived (Table 1). Infants who died
were more often outborn (transferred for care). During the ﬁrst
week after birth, infants who subsequently died from NEC more
commonly were on mechanical ventilation and vasopressors than
infants who lived (Table 2). In addition, they more often had
a report of a patent ductus arteriosus and were more likely to have
been treated with indomethacin and/or surfactant.
The diagnosis of NEC occurred later in infants who died
compared with those that lived (18 vs 15 days, Table 1, but the
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diagnosis of NEC, infants who eventually died were more often on
mechanical ventilation, and when on assisted ventilation, they
more often were supported with high frequency ventilation
(Table 3). Infants who died more commonly had a positive blood
culture (22.4 vs 14.7%, Supplementary Table) that was more often
a Gram-negative organism (11.0 vs 5.2%, Supplementary Table).
Infants who died more often received vancomycin, clindamycin,
metronidazole or carbapenem and were less often on ampicillin or
aminoglycoside than those that survived (Table 3). Speciﬁcally,
survivors were more often treated with just ampicillin and
gentamicin at the diagnosis of NEC than infants who died (11.9 vs
3.2%, Table 3). At the time of diagnosis, infants who died more
often were treated with vasopressor support and more commonly
were treated with more than one vasopressor (Table 3).
There were 605 (8.5%) infants in our study cohort who had
major anomalies (Table 1). We were unable to identify any speciﬁc
anomaly that was the primary cause of mortality and there was no
association between anomalies and overall mortality. In subgroup
analysis (presented below), the presence of a major anomaly
did increase the likelihood that infants with NEC who were
more than 32 weeks gestational age would die.
In multivariate analysis, the factors that remained
independently associated with an increased risk of death (P<0.01
in analysis) were lower EGA (in the model as a continuous
variable), lower birth weight (in the model as a continuous
variable), on assisted ventilation on the day of diagnosis of NEC
(AOR¼5.3; 95% CI (4.5 to 6.4)), on vasopressors at the time of
diagnosis (AOR¼3.8 (3.2 to 4.6)), exposure to clindamycin
(AOR¼1.2 (1.0 to 1.4)), and Black racial/ethnicity (AOR¼1.2
(1.1 to 1.5)). When interchanged with Black race, White race was
associated with a decreased risk of dying (AOR¼0.7 (0.6 to 0.8)).
Patients who received only ampicillin and gentamicin on the day
of diagnosis were less likely to die (AOR¼0.5 (0.4 to 0.7)).
Differences between infants who died within 7 days of diagnosis
and those who died 7 or more days after diagnosis of NEC
Of the 1505 infants who died, 993 (66%) died within 7 days of
diagnosis and 512 (44%) died 7 days or more after diagnosis. In
bivariate analysis, infants who died within 7 days of diagnosis were
more mature and weighed more than infants who died after 7 days.
During the ﬁrst week after birth, infants who died within 7 days of
NEC diagnosis less often were on assisted ventilation; less often had
a report of a patent ductus arteriosus; and less often were treated
with indomethacin. On the day of diagnosis of NEC, infants who
died of their NEC within 7 days of diagnosis more often were
treated with high frequency ventilation and more often were treated
with vasopressors. Infants who died late were more likely to have a
congenital anomaly (P<0.01) than infants with NEC who died
early (but presence of a congenital anomaly was not associated
with NEC death overall).
In multivariate analysis, infants who died within 7 days of
diagnosis had a higher birth weight, more often were treated with
vasopressors (OR¼2.4 (1.8 to 3.0)) and more often were treated
with high frequency ventilation at the time of diagnosis (OR¼1.5
(1.2 to 2.0)).
Subgroup analysis
Of the 9121 infants with treated NEC, 6991 (77%) were 32 weeks or
less and 2130 (23%) were more than 32 weeks EGA. Mortality was
higher in the infants that were 32 weeks or less gestational age
compared with infants with a gestational age of more than 32 weeks
(20 vs 6%, P<0.01, also see Figure 1). As most of the infants in our
study cohort were less than 32 weeks, the statistical ﬁndings in this
subgroup of infants are very similar to the overall study cohort.
Infants 32 weeks or less EGA
In infants born at an EGA of 32 weeks or less, 4034 (57.7%) lived
and were discharged home, 1555 (22%) were transferred, 1379
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Figure 1 (a) The occurrence of NEC by gestational age. (b) Mortality in infants
who had a diagnosis of NEC by EGA. The number listed within parentheses represents
the number of patients with NEC within each gestational age group. Mortality for
infants with NEC decreases with increasing gestational age. The dark bars represent
death at 7 or more days from diagnosis of NEC and the light bars represent deaths
that occurred less than 7 days from diagnosis. Although mortality decreased with
increasing gestational age, the proportion of deaths that occur within 7 days was
relatively consistent (65 to 75% of the patients who died) across all gestational ages.
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Using multivariate analysis, we compared the 4034 infants known
to have lived and been discharged home with the 1379 infants
known to have died to determine the independent risk factors
associated with death.
The factors independently associated with an increased risk
of death (P<0.01 in analysis) were lower EGA (in the model
as a continuous variable), lower birth weight (in the model
as a continuous variable), on assisted ventilation on the day of
diagnosis of NEC (AOR¼5.2; (4.3 to 6.3)), on vasopressors at the
time of diagnosis (AOR¼4; (3.3 to 4.8)), exposure to clindamycin
(AOR¼1.2; (1 to 1.4)), and Black racial/ethnicity (AOR¼1.2;
(1.1 to 1.4)). When interchanged with Black race, White
race was associated with a decreased risk of dying (AOR¼0.7
(0.6 to 0.8)). Patients who received only ampicillin and
gentamicin on the day of diagnosis were less likely to die
(AOR¼0.5 (0.4 to 0.8)).
Of the 1379 infants who died, 900 (65%) died within 7 days
of diagnosis and 479 (35%) died 7 days or more after diagnosis.
The results of multivariate analysis produced identical AOR results
to the overall group.
Infants more than 32 weeks EGA
In infants born at an EGA of more than 32 weeks, 1560 (73.3%) lived
and were discharged home, 429 (20%) were transferred, 126 (6%)
d i e d ,a n d1 5( 0 . 7 % )h a dn od a t ao nd i s c h a r g et y p e .U s i n g
multivariate analysis, we compared the 1560 infants known to have
lived and been discharged home with the 126 infants known to have
died to determine the independent risk factors associated with death.
The factors independently associated with an increased risk
of death (P<0.01 in analysis) were lower birth weight (in the
model as a continuous variable), on assisted ventilation on the day
of diagnosis of NEC (AOR¼7.2; (4.5 to 11.6)), on vasopressors at
the time of diagnosis (AOR¼8.3; (4.7 to 14.9)), and exposure to
Table 1 Demographics
Variables Lived Died P-value Died <7 days Died X7 days P-value
Number of patients 5594 1505 993 512
Prenatal variables
Maternal age, median (10–90th percentile) 26 (19–36) 26 (18–36) 0.3 26 (18–36) 26 (18–36) 0.3
Inborn 4350 (77.8) 1090 (72.4) 0.01 725 (73) 365 (71.3) 0.4
Antenatal steroids 3476 (62.1) 972 (64.6) 0.07 631 (63.5) 341 (66.6) 0.3
Maternal tocolytics 2339 (41.8) 637 (42.3) 0.7 420 (42.3) 217 (42.4) 0.9
Maternal antibiotics 2396 (42.8) 667 (44.3) 0.3 446 (44.9) 221 (43.2) 0.5
Male 3060 (54.7) 891 (59.2) 0.002 592 (59.6) 299 (58.4) 0.6
Cesarean section 3448 (61.6) 952 (63.3) 0.2 639 (64.4) 313 (61.1) 0.19
Multiples 1347 (24.1) 298 (19.8) 0.02 192 (19.3) 106 (20.7) 0.3
Race
American/Alaska native 56 (1) 17 (1.1) 0.7 12 (1.2) 5 (1) 0.8
Asian 123 (2.2) 39 (2.6) 0.8 26 (2.6) 13 (2.5) 0.8
Black 1269 (22.7) 465 (30.9) 0.01 312 (31.4) 153 (29.9) 0.5
Hispanic 1393 (24.9) 397 (26.4) 0.3 257 (25.9) 140 (27.3) 0.4
White 2478 (44.3) 494 (32.8) 0.01 333 (33.5) 161 (31.4) 0.5
Other 275 (4.9) 93 (6.2) 0.06 53 (5.3) 40 (7.8) 0.07
Perinatal variables
Gestational age, median (10–90th percentile) 30 (25–35) 26 (24–32) 0.001 26 (24–32) 25 (23–31) 0.01
Birth weight, median (10–90th percentile) 1.32 (0.72–2.5) 0.82 (0.55–1.6) 0.001 0.86 (0.6–1.7) 0.74 (0.5–1.4) 0.001
APGAR 1min, median (10–90th percentile) 7 (2–8) 5 (1–8) 0.001 5 (1–8) 5 (1–8) 0.1
APGAR 5min, median (10–90th percentile) 8 (6–9) 7 (4–9) 0.1 8 (5–9) 7 (4–9) 0.001
Severe intraventricular hemorrhage (grades 3, 4) 283 (5.1) 264 (17.5) 0.01 139 (14) 125 (24.4) 0.01
Number of patients with major anomalies
a 467 (8.3) 138 (9.2) 0.1 70 (7) 68 (13.3) 0.01
Age at diagnosis, median (10–90th percentile) 15 (4–40) 18 (7–42) 0.01 18 (7–40) 19 (7–47) 0.1
Time diagnosis to death, median (10–90th percentile) 2 (0–57) 1 (0–4) 30 (9–121) 0.001
Age at discharge, median (10–90th percentile) 60 (25–125) 27 (9–91) 0.001 19 (8–42) 53.5 (24.3–152) 0.001
aMost common anomalies were gastroschisis, trisomy 21 and heart anomalies.
Data are presented as N (%) except continuous data, which is presented as median (10–90th percentile).
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Journal of Perinatologyclindamycin (AOR¼1.8; (1.1 to 2.8)). In this subgroup,
decreasing gestational age and Black race were not independent
risk factors associated with increased mortality. Exposure to only
ampicillin and gentamicin was not associated with a decreased risk
of mortality. The presence of an anomaly was associated with an
increase risk of death (AOR¼2.6; (1.6 to 4)).
Of the 126 infants who died, 93 (74%) died within 7 days of
diagnosis and 33 (26%) died 7 days or more after diagnosis.
The small number of patients prevented us from identifying any
speciﬁc risk factors associated with death within 7 days of diagnosis.
Discussion
In a large data set of infants derived from neonatal intensive care
units across the United States, we found the overall mortality
associated with a diagnosis of NEC was high (16.5%). Mortality
decreased with increasing gestational age (Figure 1). Two-thirds of
these infants died within a week of diagnosis (with a median time
of death, 1 day after diagnosis). Infants who died quickly (<7 days
from diagnosis) were heavier than those infants who died later, but
weighed considerably less than those who survived. They also were
more often treated with vasopressors and high frequency ventilation
Table 2 Antecedent events in the ﬁrst week after birth
Variables Lived Died P-value Died <7 days Died X7 days P-value
Number of patients 5594 1505 993 512
On ventilator support in ﬁrst 48h 2612 (46.7) 1070 (71.1) 0.001 670 (67.5) 400 (78.1) 0.001
On high frequency ventilation in ﬁrst 48h 494 (8.8) 294 (19.5) 0.001 177 (17.8) 117 (22.9) 0.3
Antibiotics in the ﬁrst week 4830 (86.3) 1321 (87.8) 0.15 872 (87.8) 449 (87.7) 0.9
Positive blood culture during ﬁrst week of life 304 (5.4) 121 (8) 0.001 78 (7.9) 43 (8.4) 0.7
Surfactant 2557 (45.7) 982 (65.2) 0.001 638 (64.2) 344 (67.2) 0.3
Indomethacin any time 1280 (22.9) 560 (37.2) 0.001 346 (34.8) 214 (41.8) 0.01
PDA reported 2185 (39.1) 913 (60.7) 0.001 556 (56) 357 (69.7) 0.001
Vasopressors in the ﬁrst week
a 995 (17.8) 604 (40.1) 0.001 390 (39.3) 214 (41.8) 0.4
Abbreviation: PDA, patent ductus arteriosus.
aMost commonly used vasopressors were dopamine, dobutamine and epinephrine.
Data are presented as N (%).
Table 3 Support and medications at diagnosis of NEC
Variables Lived Died P-value Died <7 days Died X7 days P-value
Number of patients 5594 1505 993 512
Any ventilator at diagnosis 1702 (30.4) 1274 (84.7) 0.001 858 (86.4) 416 (81.3) 0.1
High frequency ventilation 224 (4) 428 (28.4) 0.001 313 (31.5) 115 (22.5) 0.01
Vasopressor reported
a 298 (5.3) 560 (37.2) 0.001 436 (43.9) 124 (24.2) 0.001
Antibiotics on day of diagnosis
Any report of a speciﬁc antibiotic
Vancomycin 2831 (50.6) 839 (55.7) 0.01 568 (57.2) 271 (52.9) 0.1
Aminoglycosides 3400 (60.8) 846 (56.2) 0.01 587 (59.1) 259 (50.6) 0.002
Ampicillin 1577 (28.2) 287 (19.1) 0.01 184 (18.5) 103 (20.1) 0.5
Cefalosporins 1325 (23.7) 387 (25.7) 0.1 255 (25.7) 132 (25.8) 0.9
Clindamycin 1473 (26.3) 588 (39.1) 0.001 424 (42.7) 164 (32) 0.001
Metronidazole 670 (12) 215 (14.3) 0.02 152 (15.3) 63 (12.3) 0.1
Carbepeniums 373 (6.7) 151 (10) 0.01 90 (9.1) 61 (11.9) 0.09
Most common combinations
Vancomycin gentamicin 891 (15.9) 167 (11.1) 0.01 110 (11.1) 57 (11.1) 0.9
Ampicillin gentamicin 667 (11.9) 48 (3.2) 0.001 30 (3) 18 (3.5) 0.6
Vancomycin cefotaxime 590 (10.5) 108 (7.2) 0.01 55 (5.5) 53 (10.4) 0.001
Ampicillin clindamycin gentamicin 389 (7) 79 (5.2) 0.02 57 (5.7) 22 (4.3) 0.27
Vancomycin clindamycin gentamicin 314 (5.6) 149 (9.9) 0.001 118 (11.9) 31 (6.1) 0.01
Abbreviation: NEC, necrotizing enterocolitis.
aMost commonly used vasopressors were: dopamine, dobutamine and epinephrine.
Data are presented as N (%).
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increasing gestational age, the likelihood of dying quickly was
uniformly distributed across all gestational ages (Figure 1).
The factors we found to be associated with mortality are similar
to the results summarized in a recent review.
3,4
Several studies show an increased risk of NEC in Black infants; this
is most often attributed to the high risk of prematurity in this group.
5,6
Holman et al.
7 showed mortality associated with NEC was higher for
Black infants than other groups. We also found racial differences
associated with NEC mortality. Black infants were most likely to die
from NEC than other races (mortality¼27%), whereas Caucasians
infants were less likely to die following NEC (mortality¼17%).
Comparison of the individual presentations of these demographic
groups revealed that Black infants were smaller and presented later in
life compared with White and Hispanic infants. It is thus unclear
whether the primary risk factor that links race with death is NEC or
extreme prematurity, as both are associated with African American race.
A positive blood culture was uncommon in infants with NEC,
even in those who died. In multivariate analysis, positive cultures
were not associated with an increased risk of death. We found that
>75% of patients who died had negative cultures; only 11% of
patients who died had a gram-negative bacterium grow from their
blood culture. The culture ﬁndings included a paucity of anaerobic
isolates, which are the only bacteria distinctly known to be capable of
generating pneumatosis. This ﬁnding is consistent with an inability to
capture and culture these organisms in the clinical setting.
8
The absence of positive blood cultures in so many infants with NEC
also indicates the possibility that infection may not be the precipitating
etiological factor for many of these infants. The possibilities of viral
infection, abnormal coagulation pathways and vascular/thrombotic
triggers that initiate NEC need further consideration.
Cotten et al.
9 reported that prolonged initial empirical antibiotic
treatment in extremely low birth weight infants was associated with an
increased risk of NEC and/or death. We found that broader spectrum
antibiotic combinations used at the time of diagnosis of NEC were not
associated with an increased likelihood of survival. In fact, the
combination of ampicillin and gentamicin was associated with the best
overall survival, whereas clindamycin was associated with an increased
risk of death. Our observations may support previous reports that
antibiotic choice
10,11 and duration inﬂuence outcome.
9 Conversely, it is
possible that physicians may have chosen broader spectrum antibiotics
to give to sicker patients. Our study demonstrates an interesting
association but cannot be used to determine causation.
Summary
Mortality among infants who have NEC remains high, and infants
who die of NEC commonly (66%) die quickly. Most of the factors
associated with mortality are related to immaturity, low birth
weight and severity of illness. Our data also provide a testable
hypothesis, namely, antibiotic choice at diagnosis of NEC may
inﬂuence outcome. A prospective study of a limited vs broad
antibiotic spectrum therapies in NEC might be valuable.
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